Edition:
United Kingdom

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

1.95USD
8 Dec 2017
Change (% chg)

$-0.40 (-17.02%)
Prev Close
$2.35
Open
$2.15
Day's High
$2.30
Day's Low
$1.75
Volume
697,589
Avg. Vol
24,715
52-wk High
$5.25
52-wk Low
$1.30

Select another date:

Fri, Dec 8 2017

BRIEF-Cancer Genetics Prices $7 Million Registered Direct Offering

* CANCER GENETICS PRICES $7 MILLION REGISTERED DIRECT OFFERING

BRIEF-Cancer Genetics Q3 loss per share $0.15

* Cancer genetics reports record third quarter 2017 revenue and 134% increase in contracted bookings from major biotech and pharmaceutical companies

BRIEF-Cancer Genetics to acquire vivoPharm

* Cancer Genetics announces transformative and accretive acquisition of vivoPharm, a global oncology & immuno-oncology discovery services company

BRIEF-Cancer Genetics reports Q2 loss per share $0.16

* Cancer Genetics Inc announces second quarter 2017 financial results, accretive acquisition and capital raise

BRIEF-DIA elects Cancer Genetics Inc's John A. (Jay) Roberts as Chairman of board

* DIA elects Cancer Genetics Inc's John A(Jay) Roberts as chairman of DIA board of directors

Select another date: